Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-02-04, Stock:PFE, The news for the past five days is as follows:
2021-01-28: NEWS1: Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know.NEWS2: Honeywell’s Global Supply Chain Chief on how the company administered 16K vaccinations in one weekend.NEWS3: Novavax Stock Surges After Covid Vaccine Proves Nearly 90% Effective.NEWS4: A Golden Era of Medicine: Join Mira Life Science Ventures CEO for Fireside Chat Feb. 4.NEWS5: Drugmakers examine effectiveness of COVID-19 vaccines and treatments against new, more infectious South African strain.NEWS6: Covid Vaccine Stocks Pop Despite WHO Guidance Against Shots In Pregnancy.NEWS7: February Outlook: Six Things To Look For Include Fed Testimony, Vaccine Progress, Big-Box Earnings.NEWS8: Doctor: 'Double masking is actually not a bad idea'.NEWS9: FOCUS-Racing the virus: Why tweaking vaccines to fight variants won't be simple.NEWS10: Doctor on COVID-19 variants: It’s becoming clear that ‘we will need boosters’.NEWS11: Sanofi (SNY) to Manufacture BioNTech's Coronavirus Vaccine.NEWS12: English health authority says AstraZeneca shot gives "reassuring" immune responses in elderly.NEWS13: As EU battles AstraZeneca shortages, U.K. races ahead with manufacture of new COVID vaccine.NEWS14: The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO.NEWS15: Moderna and Pfizer Vaccines Still Look Safe, CDC Says.NEWS16: Northern France health agency pushes back date of some first COVID vaccination doses.NEWS17: REFILE-INSIGHT-Pandemic spurs quest to enroll more Black Americans in vaccine trials.NEWS18: Novartis in Talks to Join Pharma Industry’s Covid Vaccine Push.NEWS19: Preliminary Study Finds Pfizer's COVID-19 Vaccine Effective Against UK, South Africa Variants: WSJ.NEWS20: Better Buy: Pfizer vs. BioNTech.NEWS21: Racing the virus: Why tweaking the vaccines won't be simple.NEWS22: FOCUS-Racing the virus: Why tweaking the vaccines won't be simple.NEWS23: 4 Stocks Warren Buffett Is Likely to Add to in 2021.NEWS24: CORRECTED-Swiss flag possible Moderna COVID-19 vaccine delivery shortfall -Blick.NEWS25: Pfizer to continue vaccine supply to Italy even if Rome files lawsuit: CEO to paper.NEWS26: Pfizer to continue vaccine supply to Italy even if Rome files lawsuit - CEO to paper.
2021-01-29: NEWS1: This IBD Stock Of The Day Is Eyeing Not One — But Three — Buy Points.NEWS2: J&J Slides On Less Effective Covid Vaccine; Moderna, BioNTech Pop.NEWS3: Novavax Catapults To 6-Year High After Covid Vaccine Proves Highly Effective.NEWS4: US STOCKS-Wall St drops after J&J vaccine data, GameStop effect weighs.NEWS5: Biden aims to reopen schools in 100 days.NEWS6: Doctor: You should take 'any vaccine that is authorized and available'.NEWS7: Ecuador opens probe of health minister over COVID vaccine influence peddling.NEWS8: Now More Than Ever Why Pfizer Stock Is a Buy.NEWS9: Novavax Vaccine’s Phase 3 Win Is Sending NVAX Stock to $350.NEWS10: Doctor: COVID-19 vaccines have been the ‘highlight of our response’.NEWS11: Novavax Stock Soars as Its Covid-19 Vaccine Outperforms J&J’s.NEWS12: U.S. likely to start COVID-19 vaccination in children by late spring or early summer- Fauci.NEWS13: The new South African strain is more infectious, and it’s also making COVID-19 vaccines less effective.NEWS14: Here's where the world stands in the fight against COVID-19.NEWS15: J&J Vaccine Provides Strong Shield Against Severe Covid.NEWS16: Vaccine hopes boosted by data from Novavax and J&J, but fears over new variants remain.NEWS17: European Cities Forced to Halt Vaccinations as Supply Issues Reach Crisis Point.NEWS18: Pfizer's (PFE) Key Brands Likely to Drive Its Q4 Earnings.NEWS19: Pharma Stock Roundup: JNJ, NVS Q4 Earnings, MRK & LLY's Coronavirus Updates.NEWS20: Johnson & Johnson says one-dose vaccine is 72% effective in U.S..NEWS21: Will Glaxo (GSK) Q4 Earnings Recover From Coronavirus Woes?.NEWS22: Moderna (MRNA) at High as Johnson & Johnson (JNJ) Vaccine Disappoints.NEWS23: Understanding Pfizer's Unusual Options Activity.NEWS24: J&J Vaccine Prevents Serious Illness, but Falls Short of Competitors.NEWS25: Coronavirus update: J&J vaccine 72% effective in US trial; South African strain found in US.NEWS26: EU threatens legal action to secure more doses as vaccine shortage reaches crisis point.NEWS27: Can Moderna and Pfizer Meet President Biden's Vaccine Goals?.NEWS28: Covid-19 Vaccine Trial Data Is Good News for Novavax.NEWS29: J&J COVID-19 vaccine is 72% effective in the U.S., and 66% overall in large trial.NEWS30: Better Coronavirus Stock: Johnson & Johnson vs. Pfizer.NEWS31: Look Out, Pfizer and Moderna: Here Comes Novavax.NEWS32: Why the Market Is So Bullish About Trillium Therapeutics.NEWS33: Novavax Says Its Vaccine Is 89% Effective in Britain–but Not as Effective Against the South African Variant.NEWS34: AstraZeneca to seek Japan's approval of COVID-19 vaccine as early as mid-Feb -Yomiuri.
2021-02-01: NEWS1: Bank of America downgrades Moderna stock over concerns about valuation.NEWS2: 'We need to get to a very high level of vaccination compliance across the planet before we can really slow this virus down': Expert.NEWS3: Moderna Stock: Buy the Dip?.NEWS4: Pfizer–BioNTech partnership pledges 75 million more vaccine doses to help ease the EU bloc’s shortage.NEWS5: Time for more record earnings reports from Big Tech, led by Amazon’s first $100 billion quarter.NEWS6: Pfizer Earnings: What to Look For From PFE.NEWS7: BioNTech-Pfizer partnership pledges 75 million more vaccine doses to help ease the EU bloc’s shortage.NEWS8: Why Bank of America Thinks Moderna Stock Has Gone High Enough.NEWS9: BioNTech says back on schedule to deliver COVID-19 vaccine doses to EU.NEWS10: Distribution of the COVID-19 vaccine has been ‘more of an operational challenge' than it should have been: Doctor.NEWS11: Drug/Biotech Stock Earnings on Feb 2: AMGN, PFE & CTLT.NEWS12: Another Big Week for Q4 Earnings, Econ News; ON Semi Beats.NEWS13: Novavax Surges On Highly Effective Covid Shot; Is NVAX Stock A Buy?.NEWS14: Pfizer Earnings Preview.NEWS15: BioNTech now plans to produce 2 billion doses of its COVID-19 vaccine in 2021.NEWS16: Phoenix Venture Partners LLC Raises 3rd Fund, PVP III LP.NEWS17: Pfizer, United Parcel Service, Amazon, Google and Boeing are part of Zacks Earnings Preview.NEWS18: 3 Dividend Stocks Ideal for Retirees.NEWS19: Top Earnings To Watch This Week: Amazon and Alphabet.NEWS20: Japan ramps up ultra-cold freezer output ahead of vaccine roll-out.NEWS21: AstraZeneca Boosts EU Vaccine Supply.NEWS22: EU says Pfizer/BioNTech to deliver 75 million extra vaccine doses in second quarter.NEWS23: COVAX to send AstraZeneca shot to Latin America, some states to get Pfizer too.NEWS24: Malaysia to receive first batch of Pfizer vaccines on Feb. 26 - report.
2021-02-02: NEWS1: Biden administration looks to directly ship vaccines to pharmacies.NEWS2: Pfizer Posts Strong Revenue and Big Expectations for 2021.NEWS3: Coronavirus Vaccine Maker Pfizer Posts a Mixed Q4.NEWS4: Pfizer Calls For $15 Billion In Covid Vaccine Sales; But Dives On Light Quarter.NEWS5: Pfizer’s Covid-19 vaccine is set to be one of the most lucrative drugs in the world.NEWS6: Pfizer Increased Vaccine Sales Estimate After AstraZeneca and J&J Stumbles.NEWS7: Pfizer Projects $15 Billion in 2021 Sales of Covid Vaccine.NEWS8: Doctor: We need to get vaccines 'in arms now to save lives'.NEWS9: Americans in priority groups can start getting vaccinated at some pharmacies starting Feb. 11.NEWS10: Peru regulators approve Pfizer vaccine against COVID-19 -filing.NEWS11: UPS CEO: We have delivered 36.5 million COVID-19 vaccines.NEWS12: Pfizer expects $15bn sales of Covid-19 vaccine.NEWS13: Mask mandate is an ‘imperative first step’ in fighting COVID-19: Doctor.NEWS14: Rep. Perlmutter on stimulus talks: ‘Covid is not waiting for anybody’.NEWS15: Pfizer Expects COVID-19 Vaccine To Bring $15B In Revenue This Year.NEWS16: Why Pfizer's Q4 Results Simply Don't Matter Very Much.NEWS17: Groundhog Day, But Nothing's the Same: Q4 for PFE, UPS.NEWS18: Pfizer Earnings: What Happened With PFE.NEWS19: Pfizer (PFE) Q4 Earnings Miss, Sales Beat, 2021 View Upbeat.NEWS20: Pfizer Lifts 2021 Guidance On Expectations Of $15B In Covid-19 Vaccine Sales.NEWS21: Pfizer Stock Inches Up Despite Light Fourth-Quarter Earnings.NEWS22: Pfizer Inc. to Host Earnings Call.NEWS23: Pfizer expects its COVID-19 vaccine to bring in about $15 billion in revenue this year.NEWS24: The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment.NEWS25: Pfizer (PFE) Misses Q4 Earnings Estimates.NEWS26: Doctor on coronavirus: 'We're in an arms race now'.NEWS27: Pfizer Just Reported Earnings. Here’s the One Number to Notice..NEWS28: Pfizer: Q4 Earnings Insights.NEWS29: Pfizer stock slips after profit misses expectations, while revenue beats.NEWS30: Pfizer sees about $15 billion in 2021 sales from COVID-19 vaccine.NEWS31: What's the Upside for Novavax Stock?.NEWS32: Pfizer sees $15 billion in 2021 sales from COVID-19 vaccine.NEWS33: PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2020 RESULTS AND RELEASES 5-YEAR PIPELINE METRICS.NEWS34: Will Pfizer's Latest Bad News Wipe Out a Big Chunk of Its COVID Vaccine Profits?.NEWS35: There's No Reason to Give Up on Pfizer.NEWS36: Pfizer, UPS, Exxon, Alibaba - Tuesday's Premarket Movers.NEWS37: Pfizer Misses Q4 Earnings Forecast, Sees COVID Vaccine Boost To 2021 Profits.NEWS38: Pfizer expects $15bn in Covid vaccine revenue this year.
2021-02-03: NEWS1: Vaxart Stock Crashes After Oral Covid Vaccine Fails To Produce Antibodies.NEWS2: On-demand-dental company Medbar pivots model to become COVID-19 medical service.NEWS3: Pfizer Is Ready, Even For COVID-19 Variants.NEWS4: Doctor on COVID-19 progress: 'We’re definitely not out of the woods yet'.NEWS5: Coronavirus update: US hits 1M shots per day average as scientists eye second generation COVID-19 vaccines.NEWS6: 10 Biggest Companies That Were Dropped From the Dow Jones Industrial Average (DJIA).NEWS7: This is the straightforward explanation why more COVID-19 vaccines can’t be quickly produced.NEWS8: Switzerland Declines To Approve AstraZeneca COVID-19 Vaccine - Financial Times.NEWS9: Lifted by a Short Squeeze, Vaxart Stock Sinks on Lackluster Vaccine News.NEWS10: U.S. COVID cases continue to fall, even with one-day death rate still above 3,000.NEWS11: P/E Ratio Insights for Pfizer.NEWS12: Let’s stick to facts about COVID-19 vaccines: There aren’t ‘dozens’ of drug companies who can step in to produce more.NEWS13: The U.S. Scrambles to Overcome Its Vaccine Shortage.NEWS14: GlaxoSmithKline Will Develop Next-Generation Vaccine With Biotech CureVac.NEWS15: Serbians free to pick their vaccine amid plentiful supply.NEWS16: Imcyse Enters into Research Collaboration and License Agreement for its Imotope(TM) Technology with Pfizer in Rheumatoid Arthritis.NEWS17: IBD/TIPP Poll Shows Why J&J's Covid Shot Might Face An Uphill Battle.NEWS18: Is It Too Late to Buy Pfizer Stock?.NEWS19: Amazon Had a $126 Billion Quarter, and Two More Numbers to Know.NEWS20: Pfizer (PFE) Q4 2020 Earnings Call Transcript.NEWS21: Australia places no upper age limit on Pfizer coronavirus vaccine.NEWS22: New Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine.

Answer: Rise